Regulus TherapeuticsRGLS
13F holders, Q1 2024 (March 31)1holders
$2.88avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Regulus Therapeutics Inc. (RGLS) in their 13F filings. The largest holder was NEA Management Company, LLC ($18.6M).
- Company
- Regulus Therapeutics Inc.
- CUSIP
- 75915K200
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| NEA Management Company, LLC | 1.16% | Add +232.4% | 6,467,802 | $18.6M |
"% of holder's portfolio" is RGLS's weight in each manager's 13F, not the share of Regulus Therapeutics Inc. the manager owns.